InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the full record of transactions filed by Vivo Opportunity Fund Holdings, L.P.. Director active across 1 company, notably Unicycive Therapeutics, Inc.. Cumulatively, 1 reports have been published. Activity tracked since 30 June 2026. The latest transaction was filed on 30 June 2026 (Notice of proposed sale (Form 144)). Regulator: SEC (Form 4). The full history is openly available.
1 of 1 declaration